scispace - formally typeset
Open AccessJournal ArticleDOI

Circular-dichroism studies on two murine serum amyloid A proteins

TLDR
Computer-generated surface profiles show slight differences in accessibility, hydrophilicity and flexibility between the proteins, which may help to explain why SAA2 is found in amyloid fibrils whereas SAA1 is not.
Abstract
C.d. studies have shown that mouse SAA2 (serum amyloid A2) protein has about one-half of the alpha-helix content of the SAA1 (serum amyloid A1) analogue (15 as against 32%), although secondary-structure prediction analyses based on sequence data do not suggest such a large difference between the forms. The decreased helical content may be a reflection or indication of a stronger propensity to aggregation of the SAA2 form compared with SAA1. The main elements of secondary structure in both proteins are beta-sheets/turns. Interactions with Ca2+ are accompanied by small losses in alpha-helix content, whereas binding to chondroitin-6-sulphate in the presence of millimolar Ca2+ also decreases the amount of secondary structure. However, SAA2 binding to heparan sulphate increases its beta-sheet structure, whereas with SAA1 secondary structure is not apparently altered by its interaction with heparan sulphate. Computer-generated surface profiles show slight differences in accessibility, hydrophilicity and flexibility between the proteins. Understanding these differences may help to explain why SAA2 is found in amyloid fibrils whereas SAA1 is not. In particular, a stronger tendency to aggregation might be the reason why SAA2 is deposited exclusively in these fibrils.

read more

Citations
More filters
Journal ArticleDOI

Conformational constraints for amyloid fibrillation: the importance of being unfolded.

TL;DR: In this review, recent findings are surveyed to illustrate that protein fibrillogenesis requires a partially folded conformation, which is relatively unfolded, and shares many structural properties with the pre-molten globule state.
Journal ArticleDOI

Review: History of the Amyloid Fibril

TL;DR: Chemical and physical definition of the fibrils in tissues will be needed to relate the in vitro properties of amyloid protein fibril formation in vivo to the pathogenesis ofAmyloid fibrillar formation in vitro.
Journal ArticleDOI

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

TL;DR: In amyloid deposits apo E P, component and glucosaminoglycans may be acting as 'pathological molecular chaperones' as well as a group of unrelated proteins that induce beta-pleated conformation in amyloidsogenic polypeptides.
Journal ArticleDOI

Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.

TL;DR: Interventions to prevent islet amyloid formation are emerging, with peptide and small molecule inhibitors being developed that could lead to a preservation of beta-cell mass and amelioration of the islet lesion in type 2 diabetes.
Related Papers (5)